Patents by Inventor Jennifer Fraser

Jennifer Fraser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190133163
    Abstract: This document relates to ground meat replicas, and more particularly to plant-based products that mimic ground meat, including the fibrousness, heterogeneity in texture, beefy flavor, and red-to-brown color transition during cooking of ground meat.
    Type: Application
    Filed: January 3, 2019
    Publication date: May 9, 2019
    Inventors: Ranjani Varadan, Sergey Solomatin, Celeste Holz-Schietinger, Elysia P. Cohn, Ariel Klapholz-Brown, Jennifer Woan-Yi Shiu, Aniket Kale, Jessica Karr, Rachel Fraser
  • Publication number: 20190133162
    Abstract: This document relates to ground meat replicas, and more particularly to plant-based products that mimic ground meat, including the fibrousness, heterogeneity in texture, beefy flavor, and red-to-brown color transition during cooking of ground meat.
    Type: Application
    Filed: January 3, 2019
    Publication date: May 9, 2019
    Inventors: Ranjani Varadan, Sergey Solomatin, Celeste Holz-Schietinger, Elysia P. Cohn, Ariel Klapholz-Brown, Jennifer Woan-Yi Shiu, Aniket Kale, Jessica Karr, Rachel Fraser
  • Patent number: 10224714
    Abstract: A multi-source power supply for supplying power that includes a first rectifier configured to convert a first AC power signal from a first source to a first DC power signal, a second rectifier configured to convert a second AC power signal from a second source to a second DC power signal and a common bus operatively connected to the first rectifier and the second rectifier and configured to combine a the DC power signals into a combined DC power signal, where the common bus distributes the combined DC power signal to at least one server.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: March 5, 2019
    Assignee: Twitter, Inc.
    Inventors: Jeffrey Rose, Paul Thies, Jennifer Fraser
  • Patent number: 10110041
    Abstract: A system is provided to allow for charging of a chemical storage device without a rectifier. A gate is used in conjunction with a gate controller. The gate controller monitors input voltage and opens the gate when voltage crosses a zero crossing in a first direction. The gate monitor then closes the gate when the voltage crosses a zero crossing in a second direction. This increases the chances that the output power will have voltage in a single direction. This output power is then fed to a chemical storage device, where it can be stored and used by one or more electronic devices.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: October 23, 2018
    Assignee: Keme, Inc.
    Inventors: Jeffrey Rose, Jennifer Fraser
  • Patent number: 9680390
    Abstract: A multi-source power supply for supplying power that includes a first rectifier configured to convert a first AC power signal from a first source to a first DC power signal, a second rectifier configured to convert a second AC power signal from a second source to a second DC power signal and a common bus operatively connected to the first rectifier and the second rectifier and configured to combine a the DC power signals into a combined DC power signal, where the common bus distributes the combined DC power signal to at least one server.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 13, 2017
    Assignee: Twitter, Inc.
    Inventors: Jeffrey Rose, Paul Thies, Jennifer Fraser
  • Publication number: 20170012454
    Abstract: A system is provided to allow for charging of a chemical storage device without a rectifier. A gate is used in conjunction with a gate controller. The gate controller monitors input voltage and opens the gate when voltage crosses a zero crossing in a first direction. The gate monitor then closes the gate when the voltage crosses a zero crossing in a second direction. This increases the chances that the output power will have voltage in a single direction. This output power is then fed to a chemical storage device, where it can be stored and used by one or more electronic devices.
    Type: Application
    Filed: September 26, 2016
    Publication date: January 12, 2017
    Inventors: Jeffrey Rose, Jennifer Fraser
  • Patent number: 9484770
    Abstract: A system is provided to allow for charging of a chemical storage device without a rectifier. A gate is used in conjunction with a gate controller. The gate controller monitors input voltage and opens the gate when voltage crosses a zero crossing in a first direction. The gate monitor then closes the gate when the voltage crosses a zero crossing in a second direction. This increases the chances that the output power will have voltage in a single direction. This output power is then fed to a chemical storage device, where it can be stored and used by one or more electronic devices.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: November 1, 2016
    Assignee: Keme, Inc.
    Inventors: Jeffrey Rose, Jennifer Fraser
  • Publication number: 20140159669
    Abstract: A system is provided to allow for charging of a chemical storage device without a rectifier. A gate is used in conjunction with a gate controller. The gate controller monitors input voltage and opens the gate when voltage crosses a zero crossing in a first direction. The gate monitor then closes the gate when the voltage crosses a zero crossing in a second direction. This increases the chances that the output power will have voltage in a single direction. This output power is then fed to a chemical storage device, where it can be stored and used by one or more electronic devices.
    Type: Application
    Filed: December 7, 2012
    Publication date: June 12, 2014
    Applicant: Keme, Inc.
    Inventors: Jeffrey Rose, Jennifer Fraser
  • Patent number: 8551951
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH). In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: October 8, 2013
    Assignee: Aenorasis SA Pharmaceuticals and Medical Devices
    Inventors: Seema Garde, Chandra J. Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim
  • Publication number: 20100239653
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH). In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Application
    Filed: January 22, 2010
    Publication date: September 23, 2010
    Applicant: Kotinos Pharmaceuticals Inc.
    Inventors: Seema Garde, Chandra J. Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim
  • Patent number: 7655631
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH) In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: February 2, 2010
    Assignee: Kotinos Pharmaceuticals Inc.
    Inventors: Seema Garde, Chandra Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim
  • Patent number: 7053058
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH). In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: May 30, 2006
    Assignee: Procyon Biopharma Inc.
    Inventors: Seema Garde, Chandra Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim
  • Publication number: 20060105949
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH) In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Application
    Filed: September 30, 2005
    Publication date: May 18, 2006
    Inventors: Seema Garde, Chandra Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim
  • Patent number: 6825859
    Abstract: When a content of an on-screen item representing a feature of an application program is changed without user's direct interaction, the present invention provides a visual cue that indicates the content change of the on-screen item to help attracting user's attention to the change.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: November 30, 2004
    Assignee: Corel Corporation
    Inventors: Tony Severenuk, Cory Cooperman, Jennifer Fraser, Ramesh Subramanian, Rex Fang Xu
  • Publication number: 20030189598
    Abstract: An anchor manager is described for providing a window for presenting window contents. It comprises a pane provider, an anchor indicator and a coupler. The pane provider provides multiple panes, each containing window contents. The anchor indicator provider provides multiple anchor indicators, each representing its related window contents. The coupler associates an anchor indicator to a pane that contains window contents represented by the anchor indicator so as to allow display of the panes in a display area of the window according to selection of the anchor indicators.
    Type: Application
    Filed: April 9, 2002
    Publication date: October 9, 2003
    Applicant: COREL CORPORATION
    Inventors: Shawn Lipstein, Laura Olac, Rex Fang Xu, Jennifer Fraser
  • Publication number: 20030170220
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH). In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Application
    Filed: October 15, 2001
    Publication date: September 11, 2003
    Applicant: PROCYON BIOPHARMA INC.
    Inventors: Seema Garde, Chandra Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim